Cargando…
Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease
BACKGROUND: Lipid accumulation product (LAP) and visceral adiposity index (VAI) are novel, non-imaging markers of visceral adiposity that are calculated by using body mass index (BMI), waist circumference (WC) and serum lipid concentrations. We hypothesized that LAP and VAI are more strongly associa...
Autores principales: | Bullen, Alexander L., Katz, Ronit, Kumar, Ujjala, Gutierrez, Orlando M., Sarnak, Mark J., Kramer, Holly J., Shlipak, Michael G., Ix, Joachim H., Judd, Suzanne E., Cushman, Mary, Garimella, Pranav S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753382/ https://www.ncbi.nlm.nih.gov/pubmed/36522626 http://dx.doi.org/10.1186/s12882-022-03026-9 |
Ejemplares similares
-
Association of urinary uromodulin with kidney function decline and mortality: the health ABC study
por: Garimella, Pranav S., et al.
Publicado: (2017) -
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
por: Drew, David A., et al.
Publicado: (2020) -
Urinary uromodulin, kidney function and cardiovascular disease in elderly adults
por: Garimella, Pranav S., et al.
Publicado: (2015) -
Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Malkina, Anna, et al.
Publicado: (2013) -
Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial
por: Ascher, Simon B., et al.
Publicado: (2022)